Cargando…

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort

BACKGROUND/PURPOSE: Recently, the mutational background of diffuse large B cell lymphoma (DLBCL) has been revealed, identifying specific genetic events that drive lymphomagenesis. However, the prognostic value of these mutations remains to be determined. Prognostic biomarkers in DLBCL are urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juskevicius, Darius, Jucker, David, Klingbiel, Dirk, Mamot, Christoph, Dirnhofer, Stephan, Tzankov, Alexandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356266/ https://www.ncbi.nlm.nih.gov/pubmed/28302137 http://dx.doi.org/10.1186/s13045-017-0438-7

Ejemplares similares

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study
por: Tzankov, Alexandar, et al.
Publicado: (2015)

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †
por: Genta, Sofia, et al.
Publicado: (2022)

Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin
por: Vela, Visar, et al.
Publicado: (2021)

Genetic background and evolution of relapses in aggressive B-cell lymphomas
por: Juskevicius, Darius, et al.
Publicado: (2017)

Genomic Landscape of Hodgkin Lymphoma
por: Brune, Magdalena M., et al.
Publicado: (2021)

High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations
por: Pillonel, V., et al.
Publicado: (2018)

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007)

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells
por: Burkhard, Regula, et al.
Publicado: (2019)

JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
por: Schuhmacher, Bianca, et al.
Publicado: (2019)

Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients
por: Bentivegna, Angela, et al.
Publicado: (2006)

Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC
por: Blum, David, et al.
Publicado: (2012)

Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
por: Varga, Zsuzsanna, et al.
Publicado: (2015)

Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort
por: Varga, Zsuzsanna, et al.
Publicado: (2019)

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials
por: König, D., et al.
Publicado: (2022)

A novel CREBBP mutation and its phenotype in a case of Rubinstein–Taybi syndrome
por: Wang, Qian, et al.
Publicado: (2022)

The impact of SOCS1 mutations in diffuse large B‐cell lymphoma
por: Mellert, Kevin, et al.
Publicado: (2019)

External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26
por: Herrmann, Evelyn, et al.
Publicado: (2017)

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
por: Eppenberger-Castori, Serenella, et al.
Publicado: (2020)

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
por: Tisato, Veronica, et al.
Publicado: (2014)

Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09)
por: Matter-Walstra, Klazien W, et al.
Publicado: (2014)

Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice
por: Zheng, Fei, et al.
Publicado: (2016)

Next generation sequencing identified two novel mutations in NIPBL and a frame shift mutation in CREBBP in three Chinese children
por: Tang, Hui, et al.
Publicado: (2019)

Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
por: Obermann, Ellen C, et al.
Publicado: (2005)

H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas
por: Brune, Magdalena M., et al.
Publicado: (2022)

Characterization of somatic mutations of colorectal tumor in a patient with concurrent APC and MLH1 germline mutations
por: Cheng, Yunsheng, et al.
Publicado: (2023)

The activation of p38alpha, and not p38beta, mitogen-activated protein kinase is required for ischemic preconditioning
por: Sicard, Pierre, et al.
Publicado: (2010)

DIAMUND: Direct Comparison of Genomes to Detect Mutations
por: Salzberg, Steven L, et al.
Publicado: (2014)

Biallelic mutations in UGDH cause congenital microcephaly
por: Shu, Li, et al.
Publicado: (2023)

CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
por: Xian, Rena R., et al.
Publicado: (2020)

The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP
por: Jung, Hyunchul, et al.
Publicado: (2017)

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
por: Malinowska-Ozdowy, K, et al.
Publicado: (2015)

CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome
por: Wincent, Josephine, et al.
Publicado: (2015)

Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma
por: Wang, Huan-You, et al.
Publicado: (2021)

IDH1 mutations in a Brazilian series of Glioblastoma
por: Uno, Miyuki, et al.
Publicado: (2011)

Isolated sulfite oxidase deficiency: a founder mutation
por: Mhanni, Aizeddin A., et al.
Publicado: (2020)

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
por: Brune, Magdalena M., et al.
Publicado: (2021)

Absence of Germline CHK2 Mutations in Familial Gastric Cancer
por: Kimura, Kenji, et al.
Publicado: (2000)

The roles of mitochondrial tRNA mutations in non-dystrophic myotonias
por: Yu, Xue-Jiao, et al.
Publicado: (2020)

Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP
por: Jung, Hyunchul, et al.
Publicado: (2018)

Early progression and transformation of a splenic diffuse red pulp small B-cell lymphoma with NOTCH1, ARID2, CREBBP, and TNFRSF14 gene mutations
por: Lopedote, Paolo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2v6qpr8v2gtjqlr5qa89nbv444